-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

654.P1.57 654. MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster I

Symposia: MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Ludovic Saba, MD, MSc1*, Chieh-Lin Fu, MD1, Kaylee Sarna, MS1*, Hong Liang, PhD1*, Barbara Geraldine Dominguez, MBA1*, John Greskovich Jr., MD2* and Chakra Pani Chaulagain, MD1

1Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL
2Radiation Oncology, Cleveland Clinic Florida, Weston, FL

Yoshinobu Konishi, MD, PhD1,2,3, Romanos Sklavenitis-Pistofidis, MD1,2,3, Daniel L. Mallory, BS2,3*, Ting Wu, MS3*, Michelle P. Aranha, PhD1,2,3*, Junko Tsuji, PhD3*, Nicholas J Haradhvala, PhD3*, Elizabeth D. Lightbody, PhD1,2,3, Katherine Towle, BS2*, Laura Hevenor, BS2*, Nickolas Tsakmaklis, BA4*, Xiyue Wang, BS2*, Alexa G Canning, BA2*, Christine-Ivy Liacos, MS5*, Efstathios Kastritis, MD5*, Meletios A. Dimopoulos5, Steven P. Treon, MD, PhD, FRCP1,4, Gady Getz, PhD1,3,6* and Irene M. Ghobrial, MD1,2,3

1Harvard Medical School, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
5Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
6Massachusetts General Hospital, Boston, MA

Daniel T Peters, MD1, Jacob Amburn, MD2*, Sascha Tuchman, MD3, Eben I Lichtman, MD3, Christopher Edward Jensen, MD, MSCR3, Koyal Jain, MD2*, Suzanne Lentzsch, MD, PhD4, Rajshekhar Chakraborty, MD5, Divaya Bhutani, MD6 and Samuel M Rubinstein, MD, MS3*

1Division of Hematology, University of North Carolina School of Medicine, Columbia, SC
2Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC
3Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC
4Division of Hematology & Oncology, Columbia University Medical Center, New York, NY
5Columbia University Irving Medical Center, Thornwood, NY
6Columbia University Medical Center, New York, NY

Claudia Bellofiore1*, Marco Basset, MD2*, Pietro Benvenuti3*, Mario Nuvolone, MD, PhD4*, Andrea Foli5*, Martina Nanci4*, Gianluigi Guida6*, Andrea Attanasio6*, Giampaolo Merlini, MD7*, Giovanni Palladini, MD, PhD7 and Paolo Milani, MD, PhD8

1Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy, Italy
2Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, Pavia, Italy, ITA
3Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
4Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, ITA
5Fondazione IRCCS Policlinico San Matteo, Pavia, ITA
6Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, ITA
7Amyloidosis Research and Treatment Center, University of Pavia, Pavia, Italy
8Foundation IRCCS Policlinico San Matteo, Pavia, Italy

Paolo Lopedote, MD1, Alfredo Marchetti2*, Benjamin Evans3*, Tianzeng Chen4*, Maria Moscvin, MD5*, Niccolò Bolli, MD6* and Giada Bianchi, MD7

1Department of Medicine, St Elizabeth's Medical Center, Boston, MA
2Università degli Studi di Milano, Milan, Italy
3Dana Farber Cancer Institute, Boston
4Amyloidosis Program, Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
5Stanford Healthcare, Palo Alto, CA
6U.O.C Ematologia, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy
7Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Anthea Gibbons, MBBS1*, Nirija Ranjit Anderson, MBBS2,3, Lipi Chakravorty, MBBS4*, Fiona Kwok, FRACP, FRCPA, MBBS5*, Hasib Sidiqi4*, Simon Gibbs, FRACP, FRCPA, MBBS6,7*, Dariusz Korczyk, MBBS, FRACP8*, Emad Uddin Abro, MBBS, BSc, FRACP, FRCPA9* and Peter Mollee, FRACP, MBBS, MSc, FRCPA2,10

1Haematology Department, Princess Alexandra Hospital, Brisbane, Australia
2Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia
3Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia
4Haematology Department, Fiona Stanley Hospital, Perth, Australia
5Westmead Hospital, Sydney, AUS
6University of Melbourne, Greater Melbourne Area, AUS
7Eastern Health, Box Hill, Australia
8Cardiology Department, Princess Alexandra Hospital, Woolloongabba, Australia
9Haematology Department, Princess Alexandra Hospital, Woolloongabba, Australia
10Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia

Mark Orland, MD, Danai Dima, MD, Fauzia Ullah, MD*, Hussein Awada*, Diana Basali, MD, Beth M. Faiman, PhD, CNP, Cynthia Scott, CNP*, Sandra Mazzoni, DO*, Louis S. Williams, MD, Christy J. Samaras, DO, Jason Valent, MD, Faiz Anwer, MD, Shahzad Raza, MD* and Jack Khouri, MD

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Chenqi Yu, MD1*, Jing Li, MD1*, Tianhong Xu1*, Wenjing Wang, MD1*, Pu Wang1*, Yang Yang2* and Peng Liu, MD1,3,4

1Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
2Department of Hematology, Zhongshan Hospital, Fudan University, Philadelphia, PA
3Hematology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China
4Cancer center, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China

Maxime Beydon1*, Yannick Dieudonné2*, Veronique Meignin, MD3*, Eléonore Kaphan, MD4*, Louis Terriou, M.D5*, Jean Philippe Martellosio6*, Jean-Francois Viallard, MD PhD7*, Claire Ballot-Schmit8*, Marie Emilie Dourthe, MD, PhD9*, Coralie Mallebranche, MD10*, Deborah Meyran, MD11*, Lucas Maisonobe12*, Lionel Galicier13*, Eric Oksenhendler13* and David Boutboul, MD, PhD14*

1Hôpital Saint-Louis, Paris, France
2Strasbourg University Hospital, Strasbourg, FRA
3Pathology, Hopital Saint-Louis, PARIS, FRA
4Saint-Louis Hospital, Paris, FRA
5CHU Lille, Université de Lille, Lille, France
6Poitiers University Hospital, Poitiers, France
7Service Médecine Interne, Haut-Leveque Hospital, Pessac, France
8Hopital Jean Minjoz, Besançon, France
9Department of Pediatric Hematology, Robert Debré Hospital, AP-HP, Université Paris Cité, Paris, France., Paris, France
10immuno-hemato-oncology Unit, Univ Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, CHU Angers,, Angers, FRA
11Hopital Robert Debré, Paris, France
12Hopital Bichat, Paris, France
13Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, France
14Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, Paris, France

Maciej Kabat, MD*, Tony Varughese, MD, Eli Zolotov, MD* and Jamie Koprivnikar, MD*

Hackensack University Medical Center, Hackensack, NJ

Margaret Stalker, MD1*, Alfred L. Garfall, MD, MTR2, Adam D. Cohen, MD2, Dan T. Vogl, MD, MSCE2, Sandra Susanibar-Adaniya, MD2, Mia Djulbegovic, MD, MS2, Edward A. Stadtmauer, MD2, Oxana Megherea, PharmD2 and Adam Waxman, MD2*

1Hospital of the University of Pennsylvania, Philadelphia, PA
2Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

R. Eric Heidel, PhD1*, Anne Kassira, MD2*, Emily B Martin, PhD1*, Alan Stuckey, CNMT1*, Bryan Whittle, CNMT2*, Dustin Powell, MD3*, Renju Raj, MD1, Myrwood Besozzi, MD2*, Stephen J. Kennel, PhD1* and Jonathan S. Wall, PhD1*

1University of Tennessee Graduate School of Medicine, Knoxville, TN
2University of Tennessee Medical Center, Knoxville, TN
3Hendersonville Radiologic Consultants, Hendersonville, NC

Ho Sup Lee1*, Dajung Kim, MD, PhD1,2*, Sung-Hoon Jung3*, Je-Jung Lee4*, Kihyun Kim5*, Chang-Ki Min6*, Jae Hoon Lee7*, Won-Sik Lee8*, JiHyun Lee9*, Gyeong Won Lee10*, Min Kyoung Kim11*, Ho-Jin Shin, MD12*, Hyo Jung Kim13* and Jun Ho Yi, MD14

1Department of Internal Medicine, Kosin University Gospel Hospital, Busan,, Korea, Republic of (South)
2Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea, Republic of (South)
3Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Korea, Republic of (South)
4Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
5Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
6Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
8Department of Internal Medicine,, Busan Paik Hospital, Busan, South Korea, Busan, Korea, Republic of (South)
9Department of Internal Medicine,, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea, Busan, Korea, Republic of (South)
10Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea, Republic of (South)
11Yeungnam University College of Medicine, Daegu, Korea, Daegu, Korea, Republic of (South)
12Pusan National University Hospital, Busan, Korea, Republic of (South)
13Hallym University College of Medicine, Anyang, Korea, Republic of (South)
14Chung-Ang University, Seoul, Korea, Republic of (South)

Yang Liu, M.D.1*, Xuelin Dou, M.D.1*, Lei Wen, M.D.1*, Xin Gao, PhD2*, Xiaohong Wang, MSc3* and Jin Lu, M.D.1,4*

1National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
2Medical Affairs Department, Xian Janssen Pharmaceutical Ltd., Beijing, AL, China
3Medical Affairs Department, Xian Janssen Pharmaceutical Ltd., Beijing, China
4Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China

Maha Hameed, MBBS1, Sara Abid Awan2*, Laiba Yaseen2*, Faateh Sohail2*, Jibran Khan2*, Sanket Bhattarai, MBBS3*, Iqra Effendi, MBBS4*, Gustavo Garcia, MD1*, Muhammad Salman Faisal, MD, MBBS5 and Faiz Anwer, MD6

1Florida State University / Sarasota Memorial Hospital, Sarasota, FL
2Alfaisal University College of Medicine, Riyadh, Saudi Arabia
3Bhaktapur Cancer Hospital, Bhaktapur, Nepal
4CMH Lahore Medical College and Institute of Dentistry, Lahore, Pakistan
5Roswell Park Comprehensive Cancer Center, Buffalo, NY
6Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Mahta Salehi, MD1,2, Mei Wang1,3*, Kristen M. Sanfilippo, MD1,4, Theodore Thomas, MD1,4*, Martin William Schoen, MD, MPH1,2* and Su-Hsin Chang, PhD1,3*

1St. Louis Veterans Affairs Medical Center Research Service, St. Louis, MO
2Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO
3Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO
4Department of Medicine, Washington University School of Medicine, St. Louis, MO

*signifies non-member of ASH